Cardiovascular Disease, Mortality and Prognostic Factors in Adult-onset Type 1 Diabetes

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

Scarce evidence is available for prognosis in adult-onset type 1 diabetes (T1D). The aim of this study is to investigate the risk of all-cause mortality, cause-specific mortality, and incident CVD in adult-onset T1D, as compared to type 2 diabetes with comparable age at diagnosis and population controls. We will explore potential modifiable factors including lifestyle and clinical characteristics that contribute to T1D prognosis. In addition, we will estimate the life expectancy associated with different age at T1D diagnosis as compared to population controls. This study will be based on people with diabetes recorded in Swedish National Diabetes Registers, with linkages to other nationwide registers to retrieve data on lifestyle factors, biomarkers, treatment and outcome information.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 110
Healthy Volunteers: f
View:

• people with adult-onset (≥18 years) T1D diagnosed in 2001-2020 from the National Diabetes Register

• all T2D cases diagnosed at age ≥18 years in 2001-2020 recorded in the National Diabetes Register

⁃ Everyone with T1D was matched by age, sex, and county to 50 population controls from the Total Population Register.

Locations
Other Locations
Sweden
Karolinska institute
RECRUITING
Stockholm
Contact Information
Primary
Sofia Carlsson, phd
sofia.carlsson@ki.se
0046 8 524 800 11
Backup
Yuxia Wei, phd
yuxia.wei@ki.se
0046 769266173
Time Frame
Start Date: 2024-01-01
Estimated Completion Date: 2025-07-01
Participants
Target number of participants: 900000
Treatments
population controls
Randomly sampled diabetes controls from the general Swedish population
adult-onset T1D
people who developed T1D as adults 2001-2020 in Sweden
T2D
people who developed T2D 2001-2020 in Sweden
Sponsors
Leads: Karolinska Institutet

This content was sourced from clinicaltrials.gov